JUNS
JUPITER NEUROSCIENCES, INC.
$0.2310
-4.55%
$8.4M
No data for this timeframe.
Vol
Market Cap$8.4M
Cap SizeNano Cap
Inst. Holders2 funds
Inst. Value$254.1K
Inst. Activity1 buys / 1 sells
Reddit Sentiment50° Neutral
SEC Reports3
Recent Activity
Jun 2, 2026
Insider
Brady Allison W sold 100,000 shares
Director @ $0.00 ($0.00)
Jun 2, 2026
Insider
Hayward Marshall A. sold 259,231 shares
Chief Scientific Officer @ $0.00 ($0.00)
Jun 2, 2026
Insider
Silva Alison D. sold 1,027,304 shares
President and COO @ $0.00 ($0.00)
Jun 2, 2026
short_volume
Short Volume: JUNS — 56.6% short (1.4M / 2.5M)
Short: 1,412,771 | Exempt: 1,900 | TRF Vol: 2,496,700 | Short Ratio: 56.6% | Off-exchange volume (da
May 21, 2026
SEC
Jupiter Neurosciences priced a registered direct offering of 7,142,858 shares at $0.28/share, raising ~$2.0M gross proce
8-K — Impact 6/10
May 21, 2026
SEC
Jupiter Neurosciences has priced a registered direct offering of 7,142,858 shares of common stock at $0.28 per share, ra
424B5 — Impact 6/10
Apr 27, 2026
SEC
Jupiter Neurosciences' S-3 shelf registration has become effective, allowing the company to issue unspecified amounts of
EFFECT — Impact 3/10
Inst.
VANGUARD GROUP INC — NEW
215,831 shares ($379.9K)
Analyst Ratings
2Strong Buy
4Buy
1Hold
0Sell
0Strong Sell
Latest Reports
BEARISH
8-K
6/10
Jupiter Neurosciences priced a registered direct offering of 7,142,858 shares at $0.28/share, raising ~$2.0M gross proce
May 21, 2026
BEARISH
424B5
6/10
Jupiter Neurosciences has priced a registered direct offering of 7,142,858 shares of common stock at $0.28 per share, ra
May 21, 2026
Top Institutional Holders
| Fund | Value | Move |
|---|---|---|
| VANGUARD GROUP INC | $253.9K | NEW |
| BANK OF AMERICA CORP | $145.00 | — |
Recent Insider Trades
| Date | Insider | Type | Value |
|---|---|---|---|
| Jun 2, 2026 | Brady Allison | A | $0.00 |
| Jun 2, 2026 | Hayward Marshall | A | $0.00 |
| Jun 2, 2026 | Silva Alison | A | $0.00 |
| Jun 2, 2026 | Kampf Julie | A | $0.00 |
| Jun 2, 2026 | Elmasri Saleem | A | $0.00 |
Reddit Sentiment
50°
Neutral
Bearish
Neutral
Bullish
2 institutional holders with $254.1K total value (249,073 shares) as of 2025-Q4. Top holders: VANGUARD, BANK.
Top Institutional Holders — 2025-Q4
| # | Fund | Shares | Value | % of Tracked | Last Move |
|---|---|---|---|---|---|
| 1 | VANGUARD GROUP INC | 248,931 | $253.9K | 99.9% | NEW |
| 2 | BANK OF AMERICA CORP /DE/ | 142 | $145.00 | 0.1% | — |
Recent Position Changes
| Fund | Action | Prev Shares | Curr Shares | Change % | Value | Quarter |
|---|---|---|---|---|---|---|
| VANGUARD GROUP INC | NEW | — | 215,831 | — | $379.9K | 2025-Q3 |
| UBS Group AG | NEAR_EXIT | 53,916 | 4,090 | -92.4% | $7.2K | 2025-Q3 |
| UBS Group AG | TRIM | 135,640 | 53,916 | -60.3% | $55.0K | 2025-Q2 |
| TWO SIGMA INVESTMENTS, LP | EXIT | 21,761 | 0 | -100.0% | $0.00 | 2025-Q2 |
| UBS Group AG | DOUBLED | 25 | 135,640 | +542460.0% | $82.7K | 2025-Q1 |
| TWO SIGMA INVESTMENTS, LP | NEW | — | 21,761 | — | $13.3K | 2025-Q1 |
9 unique insiders with 0 transactions. Net insider value: $0.00 ($0.00 bought, $0.00 sold).
Insider Transactions
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jun 2, 2026 | Brady Allison W | Director | A | 100,000 | $0.00 | $0.00 |
| Jun 2, 2026 | Hayward Marshall A. | Chief Scientific Officer | A | 259,231 | $0.00 | $0.00 |
| Jun 2, 2026 | Silva Alison D. | President and COO | A | 1,027,304 | $0.00 | $0.00 |
| Jun 2, 2026 | Kampf Julie B. | Director | A | 100,000 | $0.00 | $0.00 |
| Jun 2, 2026 | Elmasri Saleem | Chief Financial Officer | A | 525,565 | $0.00 | $0.00 |
| Jun 2, 2026 | ROSEN CHRISTER | CEO and Chairman | A | 747,783 | $0.00 | $0.00 |
| Jun 2, 2026 | Hemmerly Nicholas H. | Director | A | 100,000 | $0.00 | $0.00 |
| Jun 2, 2026 | Weis Holger | Director | A | 100,000 | $0.00 | $0.00 |
| Jun 2, 2026 | Rosen Alexander Gustaf Erik | Chief Administrative Officer | A | 341,843 | $0.00 | $0.00 |
3 SEC filing reports analyzed. Sentiment: 0 bullish, 2 bearish, 0 mixed, 1 neutral. Avg impact: 5.0/10.
BEARISH
8-K
6/10
Jupiter Neurosciences priced a registered direct offering of 7,142,858 shares at $0.28/share, raisin
May 21, 2026
BEARISH
424B5
6/10
Jupiter Neurosciences has priced a registered direct offering of 7,142,858 shares of common stock at
May 21, 2026
NEUTRAL
EFFECT
3/10
Jupiter Neurosciences' S-3 shelf registration has become effective, allowing the company to issue un
Apr 27, 2026
No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.
Historical analyst distribution: 86% buy across 7 analysts — 2 strong buy, 4 buy, 1 hold, 0 sell, 0 strong sell. No current recommendation available.
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q 2025-12-31 |
$0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Next Q | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Current FY 2025-12-31 |
$0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Next FY | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
Monthly Consensus History
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| Jun 1, 2026 | 2 | 4 | 1 | 0 | 0 | 86% | |
| May 1, 2026 | 2 | 4 | 1 | 0 | 0 | 86% | |
| Apr 1, 2026 | 2 | 4 | 1 | 0 | 0 | 86% | |
| Mar 1, 2026 | 2 | 4 | 1 | 0 | 0 | 86% | |
| Feb 1, 2026 | 2 | 4 | 1 | 0 | 0 | 86% | |
| Jan 1, 2026 | 2 | 4 | 1 | 0 | 0 | 86% |
Strong BuyBuyHoldSellStrong Sell
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
50°
Neutral
Bearish
Neutral
Bullish
4 mentions
2 bullish
2 bearish
4 time periods
Reddit Sentiment History
| Date | Mentions | Sentiment | Bullish | Bearish | Threads |
|---|---|---|---|---|---|
| May 28, 2026 | 1 | 60° Warm | 1 | 0 | 1 |
| May 27, 2026 | 1 | 60° Warm | 1 | 0 | 1 |
| May 20, 2026 | 1 | 40° Cool | 0 | 1 | 1 |
| May 20, 2026 | 1 | 40° Cool | 0 | 1 | 1 |
Recent Reddit Threads
$JUNS STOCK
▲ 1
💬 1
⚡ 0.5
Anyone else get wrecked by JUNS today?
▲ 1
💬 0
⚡ 0.5
Jun 2, 2026
short_volume
Short Volume: JUNS — 56.6% short (1.4M / 2.5M)
Short: 1,412,771 | Exempt: 1,900 | TRF Vol: 2,496,700 | Short Ratio: 56.6% | Off-exchange volume (dark pool + OTC)
Jun 1, 2026
short_volume
Short Volume: JUNS — 58.5% short (1.8M / 3.1M)
Short: 1,785,005 | Exempt: 341,598 | TRF Vol: 3,050,262 | Short Ratio: 58.5% | Off-exchange volume (dark pool + OTC)
May 28, 2026
short_volume
Short Volume: JUNS — 55.7% short (2.9M / 5.2M)
Short: 2,895,566 | Exempt: 40,015 | TRF Vol: 5,197,319 | Short Ratio: 55.7% | Off-exchange volume (dark pool + OTC)
May 27, 2026
other
Jupiter Neurosciences Announces Patient Enrollment Underway in Phase 2a RESET Trial in Parkinson’s Disease
<p align="center"><i>Investigational Oral Candidate JOTROL</i><sup><i>™</i></sup><i> Addresses a Parkinson’s Disease Market with No Current Disease-mo
May 21, 2026
other
Jupiter Neurosciences Announces Closing of $2.0 Million Registered Direct Offering
<p align="center"><i>Cash Runway Extended to Finance the Parkinson’s Program; Debt Paydown Improves Shareholder Equity Position </i></p>
May 20, 2026
other
Jupiter Neurosciences Announces Pricing of $2.0 Million Registered Direct Offering
<p align="justify"><b>Jupiter, FL, May 20, 2026 (GLOBE NEWSWIRE) -- </b>Jupiter Neurosciences, Inc. (NASDAQ: JUNS) ("Jupiter" or the "Company"), a c
May 20, 2026
other
Jupiter Neurosciences Secures $100M Term Sheet for Exclusive U.S. Rights to ALA-002, a Next-Generation MDMA Therapeutic from PharmAla Biotech
<p align="center"><i>Transaction Positions JUNS at the Forefront of Next-Generation MDMA-Based Therapeutics Following President Trump's April 18, 2026
May 20, 2026
short_volume
Short Volume: JUNS — 56.6% short (32.9M / 58.1M)
Short: 32,867,601 | Exempt: 774,590 | TRF Vol: 58,074,690 | Short Ratio: 56.6% | Off-exchange volume (dark pool + OTC)